Parallel Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $833 | Sell |
|
|||||
|
2025
Q1 | $1.02K | Buy |
|
|||||
|
2024
Q4 | $699 | Sell |
|
|||||
|
2024
Q3 | $942 | Buy |
|
|||||
|
2024
Q2 | $575 | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $283 | Buy |
|
|||||
|
2023
Q2 | $190 | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $0 | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $0 | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $0 | Buy |
|